Effect of baseline fluid localization on visual acuity and prognosis in type 1 macular neovascularization treated with anti-VEGF Article Swipe
Etienne Gadiollet
,
Laurent Kodjikian
,
Fanélie Vasson
,
Kenny Kodaday
,
Nicolas Chirpaz
,
Benjamin Wolff
,
F. De Bats
,
Audrey Feldman
,
Pierre Pradat
,
Pierre Gascon
,
Thibaud Mathis
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1038/s41433-024-03256-1
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1038/s41433-024-03256-1
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41433-024-03256-1
- OA Status
- hybrid
- Cited By
- 1
- References
- 35
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4401195642
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4401195642Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41433-024-03256-1Digital Object Identifier
- Title
-
Effect of baseline fluid localization on visual acuity and prognosis in type 1 macular neovascularization treated with anti-VEGFWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-07-31Full publication date if available
- Authors
-
Etienne Gadiollet, Laurent Kodjikian, Fanélie Vasson, Kenny Kodaday, Nicolas Chirpaz, Benjamin Wolff, F. De Bats, Audrey Feldman, Pierre Pradat, Pierre Gascon, Thibaud MathisList of authors in order
- Landing page
-
https://doi.org/10.1038/s41433-024-03256-1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1038/s41433-024-03256-1Direct OA link when available
- Concepts
-
Medicine, Macular degeneration, Pro re nata, Ophthalmology, Visual acuity, Choroidal neovascularization, Bevacizumab, Ranibizumab, Neovascularization, Surgery, Internal medicine, Angiogenesis, ChemotherapyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
35Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4401195642 |
|---|---|
| doi | https://doi.org/10.1038/s41433-024-03256-1 |
| ids.doi | https://doi.org/10.1038/s41433-024-03256-1 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39085593 |
| ids.openalex | https://openalex.org/W4401195642 |
| fwci | 1.19478638 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000502 |
| mesh[1].descriptor_ui | D014792 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | physiology |
| mesh[1].descriptor_name | Visual Acuity |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D008297 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Male |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D005260 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Female |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D058449 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Intravitreal Injections |
| mesh[5].qualifier_ui | Q000008 |
| mesh[5].descriptor_ui | D020533 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | administration & dosage |
| mesh[5].descriptor_name | Angiogenesis Inhibitors |
| mesh[6].qualifier_ui | Q000627 |
| mesh[6].descriptor_ui | D020533 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | therapeutic use |
| mesh[6].descriptor_name | Angiogenesis Inhibitors |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D058471 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Subretinal Fluid |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000368 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Aged |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D011446 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Prospective Studies |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D011379 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Prognosis |
| mesh[11].qualifier_ui | Q000037 |
| mesh[11].descriptor_ui | D042461 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | antagonists & inhibitors |
| mesh[11].descriptor_name | Vascular Endothelial Growth Factor A |
| mesh[12].qualifier_ui | Q000379 |
| mesh[12].descriptor_ui | D041623 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | methods |
| mesh[12].descriptor_name | Tomography, Optical Coherence |
| mesh[13].qualifier_ui | Q000188 |
| mesh[13].descriptor_ui | D057135 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | drug therapy |
| mesh[13].descriptor_name | Wet Macular Degeneration |
| mesh[14].qualifier_ui | Q000503 |
| mesh[14].descriptor_ui | D057135 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | physiopathology |
| mesh[14].descriptor_name | Wet Macular Degeneration |
| mesh[15].qualifier_ui | Q000175 |
| mesh[15].descriptor_ui | D057135 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | diagnosis |
| mesh[15].descriptor_name | Wet Macular Degeneration |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D000369 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Aged, 80 and over |
| mesh[17].qualifier_ui | Q000008 |
| mesh[17].descriptor_ui | D000069579 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | administration & dosage |
| mesh[17].descriptor_name | Ranibizumab |
| mesh[18].qualifier_ui | Q000627 |
| mesh[18].descriptor_ui | D000069579 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | therapeutic use |
| mesh[18].descriptor_name | Ranibizumab |
| mesh[19].qualifier_ui | Q000379 |
| mesh[19].descriptor_ui | D005451 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | methods |
| mesh[19].descriptor_name | Fluorescein Angiography |
| mesh[20].qualifier_ui | Q000627 |
| mesh[20].descriptor_ui | D000068258 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | therapeutic use |
| mesh[20].descriptor_name | Bevacizumab |
| mesh[21].qualifier_ui | Q000008 |
| mesh[21].descriptor_ui | D000068258 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | administration & dosage |
| mesh[21].descriptor_name | Bevacizumab |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D008875 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Middle Aged |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D006801 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Humans |
| mesh[24].qualifier_ui | Q000502 |
| mesh[24].descriptor_ui | D014792 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | physiology |
| mesh[24].descriptor_name | Visual Acuity |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D008297 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Male |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D005260 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Female |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D058449 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Intravitreal Injections |
| mesh[28].qualifier_ui | Q000008 |
| mesh[28].descriptor_ui | D020533 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | administration & dosage |
| mesh[28].descriptor_name | Angiogenesis Inhibitors |
| mesh[29].qualifier_ui | Q000627 |
| mesh[29].descriptor_ui | D020533 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | therapeutic use |
| mesh[29].descriptor_name | Angiogenesis Inhibitors |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D058471 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Subretinal Fluid |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000368 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Aged |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D011446 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Prospective Studies |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D011379 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Prognosis |
| mesh[34].qualifier_ui | Q000037 |
| mesh[34].descriptor_ui | D042461 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | antagonists & inhibitors |
| mesh[34].descriptor_name | Vascular Endothelial Growth Factor A |
| mesh[35].qualifier_ui | Q000379 |
| mesh[35].descriptor_ui | D041623 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | methods |
| mesh[35].descriptor_name | Tomography, Optical Coherence |
| mesh[36].qualifier_ui | Q000188 |
| mesh[36].descriptor_ui | D057135 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | drug therapy |
| mesh[36].descriptor_name | Wet Macular Degeneration |
| mesh[37].qualifier_ui | Q000503 |
| mesh[37].descriptor_ui | D057135 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | physiopathology |
| mesh[37].descriptor_name | Wet Macular Degeneration |
| mesh[38].qualifier_ui | Q000175 |
| mesh[38].descriptor_ui | D057135 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | diagnosis |
| mesh[38].descriptor_name | Wet Macular Degeneration |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D000369 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Aged, 80 and over |
| mesh[40].qualifier_ui | Q000008 |
| mesh[40].descriptor_ui | D000069579 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | administration & dosage |
| mesh[40].descriptor_name | Ranibizumab |
| mesh[41].qualifier_ui | Q000627 |
| mesh[41].descriptor_ui | D000069579 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | therapeutic use |
| mesh[41].descriptor_name | Ranibizumab |
| mesh[42].qualifier_ui | Q000379 |
| mesh[42].descriptor_ui | D005451 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | methods |
| mesh[42].descriptor_name | Fluorescein Angiography |
| mesh[43].qualifier_ui | Q000627 |
| mesh[43].descriptor_ui | D000068258 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | therapeutic use |
| mesh[43].descriptor_name | Bevacizumab |
| mesh[44].qualifier_ui | Q000008 |
| mesh[44].descriptor_ui | D000068258 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | administration & dosage |
| mesh[44].descriptor_name | Bevacizumab |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D008875 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Middle Aged |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D006801 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Humans |
| mesh[47].qualifier_ui | Q000502 |
| mesh[47].descriptor_ui | D014792 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | physiology |
| mesh[47].descriptor_name | Visual Acuity |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D008297 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Male |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D005260 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Female |
| type | article |
| title | Effect of baseline fluid localization on visual acuity and prognosis in type 1 macular neovascularization treated with anti-VEGF |
| biblio.issue | 16 |
| biblio.volume | 38 |
| biblio.last_page | 3168 |
| biblio.first_page | 3161 |
| topics[0].id | https://openalex.org/T10170 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2731 |
| topics[0].subfield.display_name | Ophthalmology |
| topics[0].display_name | Retinal Diseases and Treatments |
| topics[1].id | https://openalex.org/T11438 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9998000264167786 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2741 |
| topics[1].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[1].display_name | Retinal Imaging and Analysis |
| topics[2].id | https://openalex.org/T12599 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9994000196456909 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2731 |
| topics[2].subfield.display_name | Ophthalmology |
| topics[2].display_name | Retinal and Optic Conditions |
| is_xpac | False |
| apc_list.value | 3890 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4990 |
| apc_paid.value | 3890 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 4990 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8728883266448975 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2776403814 |
| concepts[1].level | 2 |
| concepts[1].score | 0.78775954246521 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q27429789 |
| concepts[1].display_name | Macular degeneration |
| concepts[2].id | https://openalex.org/C2780699112 |
| concepts[2].level | 5 |
| concepts[2].score | 0.723606526851654 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7246796 |
| concepts[2].display_name | Pro re nata |
| concepts[3].id | https://openalex.org/C118487528 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6938150525093079 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q161437 |
| concepts[3].display_name | Ophthalmology |
| concepts[4].id | https://openalex.org/C2778257484 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6533850431442261 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q555066 |
| concepts[4].display_name | Visual acuity |
| concepts[5].id | https://openalex.org/C2781359195 |
| concepts[5].level | 3 |
| concepts[5].score | 0.6228059530258179 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q5105209 |
| concepts[5].display_name | Choroidal neovascularization |
| concepts[6].id | https://openalex.org/C2777802072 |
| concepts[6].level | 3 |
| concepts[6].score | 0.45598509907722473 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q413299 |
| concepts[6].display_name | Bevacizumab |
| concepts[7].id | https://openalex.org/C2781100027 |
| concepts[7].level | 4 |
| concepts[7].score | 0.4215892553329468 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q414270 |
| concepts[7].display_name | Ranibizumab |
| concepts[8].id | https://openalex.org/C2778271429 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4190850555896759 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1281049 |
| concepts[8].display_name | Neovascularization |
| concepts[9].id | https://openalex.org/C141071460 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3231535255908966 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[9].display_name | Surgery |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.28476399183273315 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C2780394083 |
| concepts[11].level | 2 |
| concepts[11].score | 0.09909206628799438 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q539568 |
| concepts[11].display_name | Angiogenesis |
| concepts[12].id | https://openalex.org/C2776694085 |
| concepts[12].level | 2 |
| concepts[12].score | 0.08891138434410095 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[12].display_name | Chemotherapy |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8728883266448975 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/macular-degeneration |
| keywords[1].score | 0.78775954246521 |
| keywords[1].display_name | Macular degeneration |
| keywords[2].id | https://openalex.org/keywords/pro-re-nata |
| keywords[2].score | 0.723606526851654 |
| keywords[2].display_name | Pro re nata |
| keywords[3].id | https://openalex.org/keywords/ophthalmology |
| keywords[3].score | 0.6938150525093079 |
| keywords[3].display_name | Ophthalmology |
| keywords[4].id | https://openalex.org/keywords/visual-acuity |
| keywords[4].score | 0.6533850431442261 |
| keywords[4].display_name | Visual acuity |
| keywords[5].id | https://openalex.org/keywords/choroidal-neovascularization |
| keywords[5].score | 0.6228059530258179 |
| keywords[5].display_name | Choroidal neovascularization |
| keywords[6].id | https://openalex.org/keywords/bevacizumab |
| keywords[6].score | 0.45598509907722473 |
| keywords[6].display_name | Bevacizumab |
| keywords[7].id | https://openalex.org/keywords/ranibizumab |
| keywords[7].score | 0.4215892553329468 |
| keywords[7].display_name | Ranibizumab |
| keywords[8].id | https://openalex.org/keywords/neovascularization |
| keywords[8].score | 0.4190850555896759 |
| keywords[8].display_name | Neovascularization |
| keywords[9].id | https://openalex.org/keywords/surgery |
| keywords[9].score | 0.3231535255908966 |
| keywords[9].display_name | Surgery |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.28476399183273315 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/angiogenesis |
| keywords[11].score | 0.09909206628799438 |
| keywords[11].display_name | Angiogenesis |
| keywords[12].id | https://openalex.org/keywords/chemotherapy |
| keywords[12].score | 0.08891138434410095 |
| keywords[12].display_name | Chemotherapy |
| language | en |
| locations[0].id | doi:10.1038/s41433-024-03256-1 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S167047176 |
| locations[0].source.issn | 0950-222X, 1476-5454 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0950-222X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Eye |
| locations[0].source.host_organization | https://openalex.org/P4310319965 |
| locations[0].source.host_organization_name | Springer Nature |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319965 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Eye |
| locations[0].landing_page_url | https://doi.org/10.1038/s41433-024-03256-1 |
| locations[1].id | pmid:39085593 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Eye (London, England) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39085593 |
| locations[2].id | pmh:oai:HAL:hal-04672859v1 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306402512 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | HAL (Le Centre pour la Communication Scientifique Directe) |
| locations[2].source.host_organization | https://openalex.org/I1294671590 |
| locations[2].source.host_organization_name | Centre National de la Recherche Scientifique |
| locations[2].source.host_organization_lineage | https://openalex.org/I1294671590 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | info:eu-repo/semantics/article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | ISSN: 0950-222X |
| locations[2].landing_page_url | https://hal.science/hal-04672859 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11543923 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Eye (Lond) |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11543923 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5091139679 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Etienne Gadiollet |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210100596 |
| authorships[0].affiliations[0].raw_affiliation_string | Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[0].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[0].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Etienne Gadiollet |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[1].author.id | https://openalex.org/A5031143082 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3908-6716 |
| authorships[1].author.display_name | Laurent Kodjikian |
| authorships[1].countries | FR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210100596 |
| authorships[1].affiliations[0].raw_affiliation_string | Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[1].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[1].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[1].institutions[0].country_code | FR |
| authorships[1].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Laurent Kodjikian |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[2].author.id | https://openalex.org/A5106214109 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Fanélie Vasson |
| authorships[2].countries | FR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210100596 |
| authorships[2].affiliations[0].raw_affiliation_string | Centre de Recherche Clinique, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[2].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[2].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[2].institutions[0].country_code | FR |
| authorships[2].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Fanélie Vasson |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Centre de Recherche Clinique, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[3].author.id | https://openalex.org/A5047162632 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Kenny Kodaday |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210100596 |
| authorships[3].affiliations[0].raw_affiliation_string | Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[3].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[3].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kenny Kodaday |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[4].author.id | https://openalex.org/A5113122706 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Nicolas Chirpaz |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210100596 |
| authorships[4].affiliations[0].raw_affiliation_string | Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[4].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[4].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Nicolas Chirpaz |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[5].author.id | https://openalex.org/A5061836464 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4709-692X |
| authorships[5].author.display_name | Benjamin Wolff |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210109733 |
| authorships[5].affiliations[0].raw_affiliation_string | Centre Ophtalmologique Maison Rouge, Strasbourg, France |
| authorships[5].institutions[0].id | https://openalex.org/I4210109733 |
| authorships[5].institutions[0].ror | https://ror.org/01ddmwy83 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210109733 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Centre Ophtalmologique d'Imagerie et de Laser |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Benjamin Wolff |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Centre Ophtalmologique Maison Rouge, Strasbourg, France |
| authorships[6].author.id | https://openalex.org/A5052988434 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-8916-7784 |
| authorships[6].author.display_name | F. De Bats |
| authorships[6].affiliations[0].raw_affiliation_string | Pôle Vision, Clinique du Val d'Ouest, Ecully, France |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Flore De Bats |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Pôle Vision, Clinique du Val d'Ouest, Ecully, France |
| authorships[7].author.id | https://openalex.org/A5104073600 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Audrey Feldman |
| authorships[7].affiliations[0].raw_affiliation_string | Centre Ophtalmologique LEO, Hôpital Privé de l'Est Lyonnais, Saint-Priest, France |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Audrey Feldman |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Centre Ophtalmologique LEO, Hôpital Privé de l'Est Lyonnais, Saint-Priest, France |
| authorships[8].author.id | https://openalex.org/A5068762264 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-6331-8321 |
| authorships[8].author.display_name | Pierre Pradat |
| authorships[8].countries | FR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210100596 |
| authorships[8].affiliations[0].raw_affiliation_string | Centre de Recherche Clinique, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[8].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[8].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[8].institutions[0].country_code | FR |
| authorships[8].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Pierre Pradat |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Centre de Recherche Clinique, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France |
| authorships[9].author.id | https://openalex.org/A5022038026 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-2012-8808 |
| authorships[9].author.display_name | Pierre Gascon |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I21491767, https://openalex.org/I4210115034 |
| authorships[9].affiliations[0].raw_affiliation_string | Département d'Ophtalmologie, Université d'Aix-Marseille, Hôpital Nord, Marseille, France |
| authorships[9].institutions[0].id | https://openalex.org/I21491767 |
| authorships[9].institutions[0].ror | https://ror.org/035xkbk20 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I21491767 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Aix-Marseille Université |
| authorships[9].institutions[1].id | https://openalex.org/I4210115034 |
| authorships[9].institutions[1].ror | https://ror.org/029a4pp87 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210087487, https://openalex.org/I4210115034 |
| authorships[9].institutions[1].country_code | FR |
| authorships[9].institutions[1].display_name | Hôpital Nord |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Pierre Gascon |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Département d'Ophtalmologie, Université d'Aix-Marseille, Hôpital Nord, Marseille, France |
| authorships[10].author.id | https://openalex.org/A5073953558 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-1418-1872 |
| authorships[10].author.display_name | Thibaud Mathis |
| authorships[10].countries | FR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I100532134, https://openalex.org/I1294671590 |
| authorships[10].affiliations[0].raw_affiliation_string | UMR-CNRS 5510 Matéis, Université Claude Bernard Lyon 1, Villeurbanne, France |
| authorships[10].institutions[0].id | https://openalex.org/I1294671590 |
| authorships[10].institutions[0].ror | https://ror.org/02feahw73 |
| authorships[10].institutions[0].type | government |
| authorships[10].institutions[0].lineage | https://openalex.org/I1294671590 |
| authorships[10].institutions[0].country_code | FR |
| authorships[10].institutions[0].display_name | Centre National de la Recherche Scientifique |
| authorships[10].institutions[1].id | https://openalex.org/I100532134 |
| authorships[10].institutions[1].ror | https://ror.org/029brtt94 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I100532134, https://openalex.org/I203339264 |
| authorships[10].institutions[1].country_code | FR |
| authorships[10].institutions[1].display_name | Université Claude Bernard Lyon 1 |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Thibaud Mathis |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | UMR-CNRS 5510 Matéis, Université Claude Bernard Lyon 1, Villeurbanne, France |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1038/s41433-024-03256-1 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Effect of baseline fluid localization on visual acuity and prognosis in type 1 macular neovascularization treated with anti-VEGF |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10170 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2731 |
| primary_topic.subfield.display_name | Ophthalmology |
| primary_topic.display_name | Retinal Diseases and Treatments |
| related_works | https://openalex.org/W2014260690, https://openalex.org/W4390974535, https://openalex.org/W2955043754, https://openalex.org/W2366632612, https://openalex.org/W3029611346, https://openalex.org/W2128391312, https://openalex.org/W2524865039, https://openalex.org/W3031917678, https://openalex.org/W2121621777, https://openalex.org/W2531729507 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1038/s41433-024-03256-1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S167047176 |
| best_oa_location.source.issn | 0950-222X, 1476-5454 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0950-222X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Eye |
| best_oa_location.source.host_organization | https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_name | Springer Nature |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319965 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Eye |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s41433-024-03256-1 |
| primary_location.id | doi:10.1038/s41433-024-03256-1 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S167047176 |
| primary_location.source.issn | 0950-222X, 1476-5454 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0950-222X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Eye |
| primary_location.source.host_organization | https://openalex.org/P4310319965 |
| primary_location.source.host_organization_name | Springer Nature |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319965 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Eye |
| primary_location.landing_page_url | https://doi.org/10.1038/s41433-024-03256-1 |
| publication_date | 2024-07-31 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W1789824814, https://openalex.org/W2124415048, https://openalex.org/W1934543195, https://openalex.org/W2068742492, https://openalex.org/W2767373868, https://openalex.org/W2316418129, https://openalex.org/W2075984382, https://openalex.org/W2988969159, https://openalex.org/W2074575505, https://openalex.org/W2346873848, https://openalex.org/W2965769306, https://openalex.org/W3182275782, https://openalex.org/W2517716364, https://openalex.org/W2325901584, https://openalex.org/W4210389481, https://openalex.org/W1481978003, https://openalex.org/W2766820003, https://openalex.org/W2978000171, https://openalex.org/W2005976851, https://openalex.org/W4214844957, https://openalex.org/W4295763071, https://openalex.org/W2151121496, https://openalex.org/W4214582981, https://openalex.org/W2165794331, https://openalex.org/W2225799082, https://openalex.org/W4220870450, https://openalex.org/W2995905631, https://openalex.org/W3119176982, https://openalex.org/W3012096120, https://openalex.org/W3192403893, https://openalex.org/W2074385169, https://openalex.org/W2788023813, https://openalex.org/W3004143075, https://openalex.org/W2608488415, https://openalex.org/W4200418176 |
| referenced_works_count | 35 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6800000071525574 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.70422199 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |